Skip to content
DataLookout
Menu

NCT06305000

Impact of Keratinized Mucosa Augmentation on Treatment Outcomes of Peri-implant Mucositis

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved 3 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 7 versions: 6 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 10 words
    • Primary completion pushed from Sep 10, 2026 to Dec 10, 2026
    • Study completion pushed from Sep 10, 2026 to Jan 10, 2027
    • Secondary endpoints: details revised at 19 of 20 entries
  2. Notable Primary and study completion dates: Sep 10, 2025 to Sep 10, 2026
    • Enrollment target: 64 to 48
    • Study arms: 4 to 3
    v6
  3. Notable Primary and study completion dates pushed to Sep 10, 2025v5
  4. Notable Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v4
  5. Minor Start date: Mar 10, 2024 to Mar 27, 2024v3
  6. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Inflammatory parameter levels in peri-implant crevicular fluid
Timeframe: Baseline (prior to therapy)

Secondary (5)

Plaque index (Silness & Löe, 1964)
Gingival Index ( Löe & Silness,1963)
Bleeding on probing (Ainamo & Bay 1975)
Keratinized mucosa width
Probing depth

Arms and interventions

Peri-implant healthy group with sufficient keratinized mucosa (≥ 2mm)No intervention
Peri-implant mucositis group with sufficient keratinized mucosa (≥ 2mm)Experimental

Only non-surgical therapy will apply

Peri-implant mucositis group with insufficient keratinized mucosa (< 2mm) receiving FGGExperimental

Free gingival graft will apply following non-surgical therapy

Procedures: Non-surgical treatment, Free gingival graft

Sites

1 site in 1 country

  • Biruni UniversityIstanbul, Turkey (Türkiye)